It takes tens of thousands of the ground-up insects to make just a pound of the vivid red dye. Now, a biotech startup called Debut has developed a new alternative: an exact replica of carmine that ...

Why does everyone hate biotech stocks? Can Big Science create an actual business? And what are Martin Shkreli’s job prospects? We cover all that and more this week on “The Readout LOUD ...

Rubius Therapeutics, a preclinical biotech developing novel therapies based on red blood cells, filed on Friday with the SEC to raise up to $200 million in an initial public offering. The ...